Briacell Therapeutics Corp.
13F holders, Q1 2025 (March 31)14holders
$3.62avg. 13F price*
At the end of Q1 2025, 14 institutions reported holding Briacell Therapeutics Corp. in their 13F filings. The largest holders were UBS Group AG ($70K), Group One Trading LLC ($11K) and Royal Bank of Canada ($4K).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 107930208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $94K |
| Exits | 0 | $0 |
Ownership 14 holders
| UBS Group AG | 0.00% | New | 19,066 | $70K |
| Group One Trading LLC | 0.00% | New | 2,925 | $11K |
| Royal Bank of Canada | 0.00% | New | 1,000 | $4K |
| National Bank of Canada | 0.00% | New | 944 | $3K |
| SBI Securities Co., Ltd. | 0.00% | New | 600 | $2K |
| Morgan Stanley | 0.00% | New | 593 | $2K |
| Concord Wealth Partners | 0.00% | New | 333 | $1K |
| TD Waterhouse Canada Inc. | 0.00% | New | 190 | $659 |
| Osaic Holdings, Inc. | 0.00% | New | 67 | $244 |
| HHM Wealth Advisors, LLC | 0.00% | New | 66 | $241 |
| Wells Fargo & Company | 0.00% | New | 32 | $116 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 10 | $37 |
| BlackRock, Inc. | 0.00% | New | 1 | $4 |
| FNY Investment Advisers, LLC | 0.00% | New | 200 | $0 |
"% of holder's portfolio" is BRIACELL THERAPEUTICS CORP's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.